ProfileGDS4718 / 222334_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 60% 64% 59% 64% 62% 60% 58% 62% 61% 61% 60% 59% 63% 59% 58% 60% 61% 59% 58% 64% 61% 59% 59% 60% 60% 61% 59% 57% 58% 66% 58% 56% 62% 61% 59% 58% 62% 57% 62% 59% 61% 59% 59% 55% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.1517260
GSM549102patient 115, normal, homogenized [OPG study]6.4247164
GSM549104patient 119, normal, homogenized [OPG study]6.0622159
GSM549108patient 138, normal, homogenized [OPG study]6.4194264
GSM549119patient 077, normal, homogenized [OPG study]6.243162
GSM549133patient 032, cancer, homogenized [OPG study]6.1037960
GSM549139patient 042, cancer, homogenized [OPG study]5.9950258
GSM549099patient 107, normal, homogenized [OPG study]6.2234262
GSM549109patient 139, normal, homogenized [OPG study]6.2079761
GSM549110patient 046, normal, homogenized [OPG study]6.2012661
GSM549114patient 063, normal, homogenized [OPG study]6.1030160
GSM549122patient 082, normal, homogenized [OPG study]6.0868959
GSM549134patient 033, cancer, homogenized [OPG study]6.2884863
GSM549136patient 036, cancer, homogenized [OPG study]6.0075659
GSM549140patient 044, cancer, homogenized [OPG study]5.9761858
GSM549111patient 047, normal, homogenized [OPG study]6.1268360
GSM549113patient 057, normal, homogenized [OPG study]6.1358261
GSM549132patient 031, cancer, homogenized [OPG study]6.0454759
GSM549137patient 038, cancer, homogenized [OPG study]6.0028558
GSM549142patient 047, cancer, homogenized [OPG study]6.4361664
GSM549100patient 110, normal, homogenized [OPG study]6.1789961
GSM549107patient 135, normal, homogenized [OPG study]6.0152259
GSM549115patient 068, normal, homogenized [OPG study]6.0547559
GSM549116patient 072, normal, homogenized [OPG study]6.1093960
GSM549120patient 078, normal, homogenized [OPG study]6.1321560
GSM549131patient 030, cancer, homogenized [OPG study]6.2095661
GSM549118patient 074, normal, homogenized [OPG study]6.0428359
GSM549129patient 027, cancer, homogenized [OPG study]5.9686357
GSM549123patient 088, normal, homogenized [OPG study]6.0040858
GSM549124patient 006, cancer, homogenized [OPG study]6.544866
GSM549126patient 015, cancer, homogenized [OPG study]6.0125158
GSM549128patient 025, cancer, homogenized [OPG study]5.9063256
GSM549103patient 117, normal, homogenized [OPG study]6.2841262
GSM549117patient 073, normal, homogenized [OPG study]6.143561
GSM549138patient 041, cancer, homogenized [OPG study]6.0354459
GSM549141patient 045, cancer, homogenized [OPG study]6.0033558
GSM549130patient 028, cancer, homogenized [OPG study]6.2495562
GSM549101patient 111, normal, homogenized [OPG study]5.9899857
GSM549105patient 128, normal, homogenized [OPG study]6.2660962
GSM549106patient 134, normal, homogenized [OPG study]6.0141959
GSM549112patient 048, normal, homogenized [OPG study]6.1857361
GSM549125patient 011, cancer, homogenized [OPG study]6.0433459
GSM549127patient 024, cancer, homogenized [OPG study]6.1112359
GSM549135patient 035, cancer, homogenized [OPG study]5.7724155